Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 27;9:115–130. doi: 10.2147/ITT.S257443

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Papaevangelou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effect of modified IL-15 and antibodies on growth of TRAMP-C2 subcutaneous prostate tumors. (A) Tumor volumes up to day 17 post-treatment. Data are means + 1 SEM for all the tumors per group and comparisons are relative to vehicle (*p <0.05, **p <0.01, ***p <0.001 two-way ANOVA with Dunnett’s multiple comparisons post-test). (B) Survival curves of mice post-treatment (*p <0.05, **p <0.01, comparisons of equality of two survival curves using Log-rank (Mantel-Cox) test). Table shows the median survival of each group.